Drug Abuse Research Today is a free monthly online journal that collates and summarizes the latest research about Drug Abuse, including details on psychology, rehabilitation, consequences, treatment.

Application of a computational decision model to examine acute drug effects on human risk taking.

Lane SD, Yechiam E, Busemeyer JR

Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, 77030, USA. scott.d.lane@uth.tmc.edu

In 3 previous experiments, high doses of alcohol, marijuana, and alprazolam acutely increased risky decision making by adult humans in a 2-choice (risky vs. nonrisky) laboratory task. In this study, a computational modeling analysis known as the expectancy valence model (J. R. Busemeyer & J. C. Stout, 2002) was applied to individual-participant data from these studies, for the highest administered dose of all 3 drugs and corresponding placebo doses, to determine changes in decision-making processes that may be uniquely engendered by each drug. The model includes 3 parameters: responsiveness to rewards and losses (valence or motivation); the rate of updating expectancies about the value of risky alternatives (learning/memory); and the consistency with which trial-by-trial choices match expected outcomes (sensitivity). Parameter estimates revealed 3 key outcomes: Alcohol increased responsiveness to risky rewards and decreased responsiveness to risky losses (motivation) but did not alter expectancy updating (learning/memory); both marijuana and alprazolam produced increases in risk taking that were related to learning/memory but not motivation; and alcohol and marijuana (but not alprazolam) produced more random response patterns that were less consistently related to expected outcomes on the 2 choices. No significant main effects of gender or dose by gender interactions were obtained, but 2 dose by gender interactions approached significance. These outcomes underscore the utility of using a computational modeling approach to deconstruct decision-making processes and thus better understand drug effects on risky decision making in humans.

Published 7 June 2006 in Exp Clin Psychopharmacol, 14(2): 254-64.
Full-text of this article is available online (may require subscription).

© 2005-2008 Drug Abuse Research Today. All Rights Reserved.